Correlation Between Cyclacel Pharmaceuticals and Harvard Apparatus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and Harvard Apparatus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and Harvard Apparatus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and Harvard Apparatus Regenerative, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and Harvard Apparatus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of Harvard Apparatus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and Harvard Apparatus.

Diversification Opportunities for Cyclacel Pharmaceuticals and Harvard Apparatus

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cyclacel and Harvard is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and Harvard Apparatus Regenerative in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Harvard Apparatus and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with Harvard Apparatus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Harvard Apparatus has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and Harvard Apparatus go up and down completely randomly.

Pair Corralation between Cyclacel Pharmaceuticals and Harvard Apparatus

Assuming the 90 days horizon Cyclacel Pharmaceuticals is expected to generate 2.43 times more return on investment than Harvard Apparatus. However, Cyclacel Pharmaceuticals is 2.43 times more volatile than Harvard Apparatus Regenerative. It trades about 0.02 of its potential returns per unit of risk. Harvard Apparatus Regenerative is currently generating about -0.16 per unit of risk. If you would invest  1,261  in Cyclacel Pharmaceuticals on August 24, 2024 and sell it today you would lose (567.00) from holding Cyclacel Pharmaceuticals or give up 44.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy18.73%
ValuesDaily Returns

Cyclacel Pharmaceuticals  vs.  Harvard Apparatus Regenerative

 Performance 
       Timeline  
Cyclacel Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyclacel Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Preferred Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Harvard Apparatus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Harvard Apparatus Regenerative has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Harvard Apparatus is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Cyclacel Pharmaceuticals and Harvard Apparatus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyclacel Pharmaceuticals and Harvard Apparatus

The main advantage of trading using opposite Cyclacel Pharmaceuticals and Harvard Apparatus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, Harvard Apparatus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Harvard Apparatus will offset losses from the drop in Harvard Apparatus' long position.
The idea behind Cyclacel Pharmaceuticals and Harvard Apparatus Regenerative pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency